ICP-490 / InnoCare  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ICP-490 / InnoCare
NCT05719701: Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Recruiting
1/2
80
RoW
ICP-490, Dexamethasone
Beijing InnoCare Pharma Tech Co., Ltd.
Relapsed and/or Refractory Multiple Myeloma
07/25
12/25

Download Options